Search results

  • Synta Pharmaceuticals Corp.
    Synta Pharmaceuticals Corp.
    (781) 274-8200
    45 Hartwell Ave, 2421  Lexington

    CORPORATE OVERVIEW Synta Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing products for extending and enhancing the lives of patients with severe medical conditions. We have a diverse pipeline of novel, small-molecule drug candidates targetin…

  • Catalyst Consulting Group
    Catalyst Consulting Group
    (781) 863-5955
    74 Bedford St, 2420  Lexington

    Actually, the secret to our solutions is simple. We learn everything we can about you: your business, your culture, your issues, your goals. We help you clarify business objectives and identify and understand performance gaps. Then we work with you to develop specialized solutions designed specific…

  • Critical Therapeutics
    Critical Therapeutics
    (781) 402-5708
    60 Westview Street MA 02421, 2421  Lexington

    Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to the asthma drug ZYFLO

  • Equinox Group
    Equinox Group
    (781) 676-2050
    91 Hartwell Ave, 02421  Lexington

    We are able to provide unbiased, data-driven analysis with quick turnaround to meet client needs. We can assess business development targets in the clinic and estimate their future market success. Equinox Group is able to provide a rapid investigation of an asset’s clinical innovation and potential…

  • Microbia PE
    Microbia PE
    781.259.7600
    60 Westview St, 02421-3108  Lexington

    09.13.10 Almirall and Ironwood Announce Positive Results from a Phase 3 Trial with Linaclotide in Patients with Irritable Bowel Syndrome with Constipation - Top-line results of the Phase 3 study with linaclotide show that both primary and main secondary endpoints were met and was well tolerated.